Global Medical Plastics Market Research Report 2022-2027

IMARC Group has recently released a new research study titled "Medical Plastics Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027", the global medical plastics market size reached US$ 24.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 36 Billion by 2027, exhibiting a growth rate (CAGR) of 6.9% during 2022-2027.

Image

Medical plastics are produced using medical-grade polypropylene (PP), hypoallergenic, biocompatible, and polycarbonate materials. They are shatter-proof, chemical, temperature, and corrosion-resistant, non-permeable, and can undergo frequent sterilization cycles. Medical plastics are used explicitly for healthcare applications, such as manufacturing vials, beakers, tamper-proof caps, inhalation masks, intravenous (IV) tubes, bedpans, pill casings, prosthetics, surgical instruments, and catheters. Apart from this, they are used to transport biohazardous materials due to their antimicrobial surfaces, further preventing the spread of pathogens. Silicon, polymer blends, synthetic rubber, high performance, and engineering plastics are some of the commonly available variants in the market.

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

Request a Free PDF Sample of the Report:
https://www.imarcgroup.com/medical-plastics-market/requestsample

Market Trends:

The recent COVID-19 outbreak has significantly increased the demand for single-use medical plastics and consumables across healthcare centers, which represents one of the primary factors driving the medical plastics market growth. Moreover, the rising investments by governments of several nations to improve the healthcare infrastructure is providing a considerable boost to the market growth. Besides this, the increasing environmental awareness has compelled key players to introduce medical plastics with enhanced biocompatibility, which is bolstering the market growth. Apart from this, the rising geriatric population, increasing prevalence of cardiovascular diseases (CVDs), and rapidly expanding medical industry are some factors creating a positive outlook for the market.

Competitive Landscape with Key Players:

The competitive landscape of the global medical plastics market has been studied in the report with the detailed profiles of the key players operating in the market.

Major Players Covered:

  • Arkema SA
  • BASF SE
  • Celanese Corporation
  • Covestro AG
  • Dow Inc
  • DuPont de Nemours Inc
  • Evonik Industries AG
  • Exxon Mobil Corporation
  • SABIC
  • Solvay S.A.
  • The Lubrizol Corporation (Berkshire Hathaway Inc.)
  • Trinseo S.A.

Report Segmentation:

The report has segmented the global medical plastics market on the basis of material, application and region.

Breakup by Material:

  • Polyvinyl Chloride (PVC)
  • Polypropylene (PP)
  • Engineering Plastics
  • Polyethylene (PE)
  • Polystyrene (PS)
  • Silicones

Breakup by Application:

  • Disposables
  • Drug Delivery Devices
  • Diagnostic Instruments
  • Catheters
  • Surgical Instruments
  • Others

Geographical Analysis:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=3929&flag=C

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
Read Newsletter: https://www.linkedin.com/newsletters/industry-news-about-6929400456628637696